Nosocomial consequences of antibiotic usage

Insights

Antibiotic resistance in Pseudomonas aeruginosa significantly increased at Laiko General Hospital, particularly with amikacin. Urgent policy changes are needed to combat rising multidrug-resistant strains.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Gentamicin was the primary antibiotic in 1979, with Pseudomonas aeruginosa resistance reaching 55% within seven years.
  • Amikacin introduction in 1983 led to a rapid increase in resistance, reaching 23% within three years.
  • By 1985, resistance to aminoglycosides and third-generation cephalosporins exceeded 50%.

Purpose of the Study:

  • To analyze the trends of antibiotic resistance in Pseudomonas aeruginosa at Laiko General Hospital.
  • To identify sources and characteristics of multidrug-resistant strains.
  • To evaluate the impact of antibiotic consumption on resistance patterns.

Main Methods:

  • Retrospective analysis of antibiotic resistance data from 1979 to 1985.
  • Correlation of resistance patterns with antibiotic consumption data.
  • Identification of resistance mechanisms (AAC(6')I) and serotypes (O:12) in resistant strains.

Main Results:

  • Urine samples were the primary source of multidrug-resistant strains; amikacin-resistant strains were implicated in 50% of bacteremias.
  • The Intensive Care Unit (ICU) was the most common isolation source, with resistant strains spreading hospital-wide.
  • Multidrug-resistant strains were associated with an 11% mortality rate; AAC(6')I was detected in 60% of amikacin-resistant strains.

Conclusions:

  • Rising antibiotic resistance, especially to amikacin, poses a significant threat at Laiko General Hospital.
  • High antibiotic consumption, with amikacin and newer cephalosporins as first-line agents, correlates with resistance.
  • Urgent revisions to antibiotic policies are essential to mitigate the spread of multidrug-resistant Pseudomonas aeruginosa.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...